The Latest Breaking News from FDA

Plus: San Francisco claims to have "significantly disrupted" sex trafficking, a nationwide injunction on abortion pills, and more...

The stock market is expected to remain volatile in the near term as investors remain anxious about the Fed’s actions. Amid high recession worries, fundamentally strong healthcare stocks, Pfizer (PFE), Bristol-Myers Squibb (BMY), Amgen (AMGN), and Elevance Health (ELV), which have the potential to withstand any market downturns, could be…

Apellis Pharmaceuticals’ (APLS) stock has jumped more than 25% year-to-date based on FDA approval for treating geographic atrophy. Despite the breakthrough, the company’s ability to scale up production remains a concern. Moreover, its closest competitor is also close to getting approval. Given its poor financials, stretched valuation, and weak profitability,…

Skincare and cosmetics companies have started touting the importance of "clean beauty," but what does that really mean?

Drugmaker Eli Lilly on Wednesday said it will drop prices on some versions of insulin, and cap monthly out-of-pocket costs at $35 per product for insured individuals not covered by Medicare’s prescription drug program, which also maintains a $35 cap. The welcome move comes as lawmakers in both major parties…

Boja Kragulj, an accomplished clarinetist who once performed with orchestras in New York, Philadelphia and Jacksonville, Florida, has already lost four teeth. And she expects to lose at least a dozen more.

Last September, the FDA proposed an updated definition of the food label to incorporate new research on nutrition

BALTIMORE — A decision is due any day from a federal court in Texas that could have sweeping repercussions on abortion access across the country — including in states, like Maryland, where the procedure is protected.

The 20 states where Walgreens won't sell mifepristone include some where abortion remains legal. It's not clear whether other retail pharmacies will follow suit.